home page

Management Team

John S. Andrews, PhD, President and Chief Scientific Officer
Tom Lategan DPhil, Vice President of Regulatory Affairs

Leadership

Management Team
Board of Directors
Board Observers
Scientific Advisory Board



Tom Lategan DPhil, Vice President of Regulatory Affairs

Dr Lategan has over 20 years of experience in pharmaceutical regulatory strategy with Actelion, The Medicines Company, Roche, and was most recently Vice President of Regulatory Affairs at Panacos. He has a successful drug development history including Tracleer, Zavesca, Angiomax and Aurorix and earned his doctorate in Pharmacology from the University of Oxford.

Home | NeurAxon | Market | Pipeline | Research | News | Contact